Literature DB >> 17652879

Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease.

Yutaka Saito1, Ken-ichiro Sasaki, Yousuke Katsuda, Toyoaki Murohara, Yoshiaki Takeshita, Teiji Okazaki, Ken Arima, Yoshio Katsuki, Satoshi Shintani, Toshifumi Shimada, Hidetoshi Akashi, Hisao Ikeda, Tsutomu Imaizumi.   

Abstract

BACKGROUND: Thromboangiitis obliterans, also known as Buerger's disease, is characterized by peripheral occlusive changes in the arteries of the upper and lower limbs and treatment is often ineffective. Intramuscular transplantation of autologous bone marrow-mononuclear cells (BM-MNC) has been recently reported as improving the symptoms and clinical manifestations in patients with severely ischemic limbs, mostly caused by arteriosclerosis obliterans. The present study focused on the patients with Buerger's disease presenting with rest pain and/or skin ulcer uncontrolled by conventional treatments. METHODS AND
RESULTS: Fourteen patients with Buerger's disease (Fontaine III: n=2, Fontaine IV: n=12) underwent transplantation of autologous BM-MNC into ischemic skeletal muscles of either the upper or lower limb. After 4 weeks, rest pain was significantly reduced. In 19 skin ulcers of 9 patients, 8 ulcers were healed and 8 were diminished in the size. These improvements were maintained for 24 weeks without complications.
CONCLUSIONS: In patients with Buerger's disease, intramuscular transplantation of autologous BM-MNC improved symptoms and clinical manifestations, especially skin ulcer.

Entities:  

Mesh:

Year:  2007        PMID: 17652879     DOI: 10.1253/circj.71.1187

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  18 in total

1.  Treatment of pressure ulcers with autologous bone marrow nuclear cells in patients with spinal cord injury.

Authors:  J González Sarasúa; S Pérez López; M Alvarez Viejo; M Pérez Basterrechea; A Fernández Rodríguez; A Ferrero Gutiérrez; J García Gala; Y Menéndez Menéndez; D Escudero Augusto; A Pérez Arias; J Otero Hernández
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

Review 2.  Modulating the vascular response to limb ischemia: angiogenic and cell therapies.

Authors:  John P Cooke; Douglas W Losordo
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

3.  Thromoboagiitis Obliterans (TAO).

Authors:  Ui-Jun Park; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

Review 4.  Cell therapy of peripheral arterial disease: from experimental findings to clinical trials.

Authors:  Zankhana Raval; Douglas W Losordo
Journal:  Circ Res       Date:  2013-04-26       Impact factor: 17.367

5.  Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients.

Authors:  S Fadilah Abdul Wahid; Nor Azimah Ismail; Wan Fariza Wan Jamaludin; Nor Asiah Muhamad; Muhammad Khairul Azaham Abdul Hamid; Hanafiah Harunarashid; Nai Ming Lai
Journal:  Cochrane Database Syst Rev       Date:  2018-08-29

6.  Clinical features and predictors of patients with critical limb ischemia who responded to autologous mononuclear cell transplantation for therapeutic angiogenesis.

Authors:  Naoyoshi Aoyama; Makoto Nishinari; Shinichi Ohtani; Akifumi Kanai; Chiharu Noda; Mitsuhiro Hirata; Akira Miyamoto; Masafumi Watanabe; Tohru Minamino; Tohru Izumi; Jyunya Ako
Journal:  Heart Vessels       Date:  2017-03-29       Impact factor: 2.037

7.  Successful treatment of thromboangiitis obliterans (Buerger's disease) with immunoadsorption: results of a pilot study.

Authors:  Gert Baumann; Verena Stangl; Peter Klein-Weigel; Karl Stangl; Michael Laule; Kathrin Enke-Melzer
Journal:  Clin Res Cardiol       Date:  2011-03-05       Impact factor: 5.460

Review 8.  Emerging hurdles in stem cell therapy for peripheral vascular disease.

Authors:  Xabier L Aranguren; Catherine M Verfaillie; Aernout Luttun
Journal:  J Mol Med (Berl)       Date:  2008-08-19       Impact factor: 4.599

9.  Cell Therapy and Critical Limb Ischemia: Evidence and Window of Opportunity in Obesity.

Authors:  Sally L Elshaer; Renee E Lorys; A B El-Remessy
Journal:  Obes Control Ther       Date:  2016-09-15

10.  Human primary CD34+ cells transplantation for critical limb ischemia.

Authors:  Weishuai Lian; Xiaoxiao Hu; Long Pan; Shilong Han; Chuanwu Cao; Zhongzhi Jia; Maoquan Li
Journal:  J Clin Lab Anal       Date:  2018-06-11       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.